JP2010527365A5 - - Google Patents

Download PDF

Info

Publication number
JP2010527365A5
JP2010527365A5 JP2010508500A JP2010508500A JP2010527365A5 JP 2010527365 A5 JP2010527365 A5 JP 2010527365A5 JP 2010508500 A JP2010508500 A JP 2010508500A JP 2010508500 A JP2010508500 A JP 2010508500A JP 2010527365 A5 JP2010527365 A5 JP 2010527365A5
Authority
JP
Japan
Prior art keywords
amino
alkyl
ethyl
methyl
hydrogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2010508500A
Other languages
English (en)
Japanese (ja)
Other versions
JP2010527365A (ja
JP5248600B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2008/062808 external-priority patent/WO2008144223A2/en
Publication of JP2010527365A publication Critical patent/JP2010527365A/ja
Publication of JP2010527365A5 publication Critical patent/JP2010527365A5/ja
Application granted granted Critical
Publication of JP5248600B2 publication Critical patent/JP5248600B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2010508500A 2007-05-16 2008-05-07 トリアゾリルアミノピリミジン化合物 Expired - Fee Related JP5248600B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US93834707P 2007-05-16 2007-05-16
US60/938,347 2007-05-16
PCT/US2008/062808 WO2008144223A2 (en) 2007-05-16 2008-05-07 Triazolyl aminopyrimidine compounds

Publications (3)

Publication Number Publication Date
JP2010527365A JP2010527365A (ja) 2010-08-12
JP2010527365A5 true JP2010527365A5 (cg-RX-API-DMAC7.html) 2011-06-16
JP5248600B2 JP5248600B2 (ja) 2013-07-31

Family

ID=39951591

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2010508500A Expired - Fee Related JP5248600B2 (ja) 2007-05-16 2008-05-07 トリアゾリルアミノピリミジン化合物

Country Status (15)

Country Link
US (1) US8063035B2 (cg-RX-API-DMAC7.html)
EP (1) EP2155734A2 (cg-RX-API-DMAC7.html)
JP (1) JP5248600B2 (cg-RX-API-DMAC7.html)
KR (1) KR101131261B1 (cg-RX-API-DMAC7.html)
CN (1) CN101679395B (cg-RX-API-DMAC7.html)
AR (1) AR066473A1 (cg-RX-API-DMAC7.html)
AU (1) AU2008254319B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0811433A2 (cg-RX-API-DMAC7.html)
CA (1) CA2691997A1 (cg-RX-API-DMAC7.html)
CL (1) CL2008001323A1 (cg-RX-API-DMAC7.html)
EA (1) EA016781B1 (cg-RX-API-DMAC7.html)
MX (1) MX2009012228A (cg-RX-API-DMAC7.html)
PE (1) PE20090216A1 (cg-RX-API-DMAC7.html)
TW (1) TW200908981A (cg-RX-API-DMAC7.html)
WO (1) WO2008144223A2 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7964729B2 (en) 2006-08-28 2011-06-21 Massachusetts Institute Of Technology Sox-based kinase sensor
EP2125793B1 (en) 2006-12-21 2010-09-01 Eli Lilly & Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
HRP20100641T1 (hr) 2006-12-21 2010-12-31 Eli Lilly And Company Imidazolidinonilaminopirimidinski spojevi za liječenje raka
US8440835B2 (en) 2007-02-26 2013-05-14 Massachusetts Institute Of Technology Environmentally sensitive fluorophores
CN101679395B (zh) 2007-05-16 2012-06-13 伊莱利利公司 三唑基氨基嘧啶化合物
CA2687474A1 (en) 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds
KR101123178B1 (ko) * 2009-04-09 2012-06-13 (주)에스메디 2-아릴벤조싸이오펜 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 함유하는 퇴행성 뇌질환의 진단 또는 치료용 약학적 조성물
JP2013502901A (ja) * 2009-08-25 2013-01-31 オンコセラピー・サイエンス株式会社 がんの治療および診断の標的遺伝子としてのercc6l
US8409820B2 (en) 2009-08-31 2013-04-02 Massachusetts Institute Of Technology Kinase sensors
UA119247C2 (uk) 2013-09-06 2019-05-27 РОЙВЕНТ САЙЕНСИЗ ҐмбГ Спіроциклічні сполуки як інгібітори триптофангідроксилази
US9611201B2 (en) * 2015-03-05 2017-04-04 Karos Pharmaceuticals, Inc. Processes for preparing (R)-1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanol and 1-(5-chloro-[1,1′-biphenyl]-2-yl)-2,2,2-trifluoroethanone
CN109415366B (zh) * 2016-06-23 2022-02-22 豪夫迈·罗氏有限公司 [1,2,3]三唑并[4,5-d]嘧啶衍生物
WO2020068600A1 (en) * 2018-09-24 2020-04-02 Rapt Therapeutics, Inc. Ubiquitin-specific-processing protease 7 (usp7) modulators and uses thereof
KR20220059951A (ko) * 2019-09-05 2022-05-10 더 유니버시티 오브 멜버른 질화 억제제
CN112341428A (zh) * 2020-11-04 2021-02-09 菏泽鸿特药业有限公司 一种噻吩-2-乙胺的生产方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4929726A (en) * 1988-02-09 1990-05-29 Georgia State University Foundation, Inc. Novel diazines and their method of preparation
WO2004063192A1 (en) 2003-01-10 2004-07-29 Pharmacopeia Drug Discovery, Inc. Imidazolyl pyrimidine derivatives useful as il-8 receptor modulators
GB0308466D0 (en) 2003-04-11 2003-05-21 Novartis Ag Organic compounds
US7329764B2 (en) * 2003-07-31 2008-02-12 Boehringer Ingelheim Pharmaceuticals, Inc. Substitute benzothiophene compounds
CA2590939C (en) * 2004-12-17 2011-10-18 Amgen Inc. Aminopyrimidine compounds and methods of use
TW200800201A (en) 2005-11-18 2008-01-01 Lilly Co Eli Pyrimidinyl benzothiophene compounds
MX2008012482A (es) 2006-03-31 2008-10-10 Abbott Lab Compuestos de indazol.
HRP20100641T1 (hr) * 2006-12-21 2010-12-31 Eli Lilly And Company Imidazolidinonilaminopirimidinski spojevi za liječenje raka
EP2125793B1 (en) 2006-12-21 2010-09-01 Eli Lilly & Company Imidazolidinonyl aminopyrimidine compounds for the treatment of cancer
CN101679395B (zh) 2007-05-16 2012-06-13 伊莱利利公司 三唑基氨基嘧啶化合物
CA2687474A1 (en) * 2007-05-16 2008-11-27 Eli Lilly And Company Triazolyl aminopyrimidine compounds

Similar Documents

Publication Publication Date Title
JP2010527365A5 (cg-RX-API-DMAC7.html)
JP2014515013A5 (cg-RX-API-DMAC7.html)
JP2009502743A5 (cg-RX-API-DMAC7.html)
CY1122860T1 (el) 3,5-διαμινο-6-χλωρο-ν-(ν-(4-(4-(2-(εξυλ(2,3,4,5,6-πενταϋδροξυεξυλ)αμινο)αιθοξυ)φαινυλ)βουτυλ)καρβαμιμιδοϋλ)πυραζινο-2-καρβοξαμιδιο
JP2014139226A5 (cg-RX-API-DMAC7.html)
JP2010521514A5 (cg-RX-API-DMAC7.html)
JP2010513478A5 (cg-RX-API-DMAC7.html)
JP2015024998A5 (cg-RX-API-DMAC7.html)
JP2012509263A5 (cg-RX-API-DMAC7.html)
JP2010523692A5 (cg-RX-API-DMAC7.html)
JP2012530705A5 (cg-RX-API-DMAC7.html)
JP2011513196A5 (cg-RX-API-DMAC7.html)
JP2012532874A5 (cg-RX-API-DMAC7.html)
JP2012507535A5 (cg-RX-API-DMAC7.html)
JP2012136541A5 (cg-RX-API-DMAC7.html)
JP2011219478A5 (cg-RX-API-DMAC7.html)
JP2006526031A5 (cg-RX-API-DMAC7.html)
JP2013518107A5 (cg-RX-API-DMAC7.html)
JP2015537020A5 (cg-RX-API-DMAC7.html)
JP2012502885A5 (cg-RX-API-DMAC7.html)
JP2013534248A5 (cg-RX-API-DMAC7.html)
JP2013032389A5 (cg-RX-API-DMAC7.html)
JP2018529770A5 (cg-RX-API-DMAC7.html)
JP2012255026A5 (cg-RX-API-DMAC7.html)
JP2008533007A5 (cg-RX-API-DMAC7.html)